ArticleJournal of family medicine and primary care2025
Obesity as a risk factor for COVID-19 breakthrough infection among the fully vaccinated urban population of South Gujarat - A retrospective cohort study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: There is more possibility of COVID-19 among obese people; hence, research into how well vaccinations work in this population should be focused. More scientific studies are required to document the effect of body mass index (BMI) on the usefulness of the adenovirus vector vaccine as reviews are lacking. This study was done to see the association between obesity with COVID-19 infections due to poor vaccine response among them. Methods: A cohort of fully vaccinated individuals of a city in western India were contacted, and a retrospective cohort study was conducted. An average of 400-425 participants among the obese group (exposed) and an average of 400-425 participants among the nonobese group were taken. Data on sociodemographic details, vaccination status, height and weight for BMI calculation, COVID-19 infection status, and its clinical features were collected using predesign, pretested, semistructured questionnaires. Societies were randomly selected from eight different zones of the city, and all the eligible individuals of the society available at the time of survey were interviewed. Data entry and analysis were done using Microsoft excel, Open Epi, Quantpsy, and SPSS-16 software. Relative risk and odds ratios were calculated in open epi software. Results: The ratio of obese to nonobese individuals was 1:1. Accordingly, 409 obese and 409 nonobese participants were recruited. The mean age of participants was 41.3 ± 14.9 years. As high as 144 (17.6%) of respondents were having history of previous infection before vaccination, and around 42 (5.1%) respondents of the overall study population were infected after the first dose of vaccination. The total count of people for infections before receiving a single dose of vaccination irrespective of body status was reported to be 144 (17.6%) out of a total of 818 candidates. Interpretation and Conclusions: We can conclude that not only obesity is a risk factor but also it increases the severity of COVID-19 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.